Tag: pharma
-
![To Invest or Not: BetterLife Pharma (BETR.C)]()
To Invest or Not: BetterLife Pharma (BETR.C)
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
-
Can scrappy Valeo Pharma (VPH.C) win a Stanley Cup?
“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives,” stated Saviuk.
-
![That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster]()
That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”
-
Valeo Pharma (VPH.c) and why you should care about bioflavonoids
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled with various issues such as failed management promises, lackluster progress, heavily diluted share structure, etc… As a result, it makes it even more satisfying to introduce our audience to companies…
-
Valeo Pharma Inc. (VPH.C) – THE undervalued biotech play
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38% returns on your investment. Better yet, if you had bought Valeo’s stock a month ago, you would have been up close to 184%, which, y’know, is…
-
![World Class Extractions (PUMP.C) partners with Canopy’s (WEED.T) medical division]()
World Class Extractions (PUMP.C) partners with Canopy’s (WEED.T) medical division
“Spectrum Therapeutics’ medical patients can have confidence that their legal cannabis purchases will arrive at their door in a safe and timely fashion,” stated Rosy Mondin, CEO of World-Class
-
![Predictmedix (PMED.C) killing it on new COVID-19 screening tech]()
Predictmedix (PMED.C) killing it on new COVID-19 screening tech
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days, on the back of news it’s being used by a large events company, and financials that show a very short road to profitability. For those that haven’t been paying attention…
-
![World Class (PUMP.C) spikes 25% on agreement to purchase Pineapple Express]()
World Class (PUMP.C) spikes 25% on agreement to purchase Pineapple Express
March, 2020 PED revenues increased 265% from those in January, 2020 – as the company’s operations ramp up to satisfy growing demand.
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
![World Class (PUMP.C)/Canntab JV receives cannabis extraction licences]()
World Class (PUMP.C)/Canntab JV receives cannabis extraction licences
World Class has begun to deliver the BOSS C02 Extraction Systems along with peripheral equipment to Canntab’s Markham facility. The facility is fully scalable – further BOSS systems are expected to be deployed as demand increases.
